Clinical Trial Update: A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia. [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of PDFE-2304 topical solution for androgenetic alopecia; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• PDFE-2304 Topical Solution

Snippet

Sponsor: PDFE Pharma Innovations FZCO | Conditions: Alopecia, Androgenetic, Baldness | Phase 2 | Status: ACTIVE_NOT_RECRUITING